8,083.80-170.0
Stock Analysis, IPO, Mutual Funds, Bonds & More

Pune based Mylab becomes first Indian company to get Covid-19 test kits validated

In the current lab based testing it takes four hours for test results to come out, Mylab's turn around time is 2 1/2 hours, said Dr Gautam Wankhde, Medical Director Mylab to ET. The company's kits can study 1000 samples from large labs and 200 from smaller labs. Mylabs is looking to price its kits around INR 1200.

, ET Bureau|
Last Updated: Mar 24, 2020, 12.46 PM IST
0Comments
Agencies
18
Representative image
MUMBAI: Pune based molecular diagnostic company Mylab becomes the first Indian company to have received the validation for its Covid-19 diagnostic test kits also known as the Reverse transcription polymerase chain reaction (RT-PCR) tests by the Drug Controller of India, after the National Institute of Virology validated its test. The other company to have received the approval is Germany's Altona Diagnostics.

In the current lab based testing it takes four hours for test results to come out, Mylab's turn around time is 2 1/2 hours, said Dr Gautam Wankhde, Medical Director Mylab to ET. The company's kits can study 1000 samples from large labs and 200 from smaller labs. Mylabs is looking to price its kits around INR 1200.

As India fights the Covid-19 spread the government has come under criticism for not doing enough tests. The Indian Council of Medical Research has so far limited the tests only for patients with travel history and those who are "suspected cases" of Covid-19. India ranks lowest in terms of testing done per million population. It is testing 15 people in 1 million.

However the government's research body has been looking to expand its testing criteria. It allowed few private labs to start providing tests under a prescription from qualified doctor. However these labs can't start testing unless they get the reagents or testing kits required to start these tests.

Mylab has promised that it can manufacture up to 1 lakh tests in a week which can be further scaled up if needed.
Comments
Add Your Comments
Commenting feature is disabled in your country/region.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service